Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-09-01
著者
関連論文
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long-term survival
- Enhancement of mitochondrial gene expression in the liver of primary biliary cirrhosis
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Hepatitis B virus mutations associated with lamivudine therapy in patients with chronic hepatitis B
- Changes of HCV quasispecies during combination therapy with interferon and ribavirin
- Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy
- Pegylated Interferon-Associated Retinopathy in Chronic Hepatitis C Patients
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan
- Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
- Clinical Characteristics of Patients who Developed Hepatocellular Carcinoma after Hepatitis C Virus Eradication with Interferon Therapy: Current Status in Japan
- Cancer preventive effect of pegylatecl interferon α-2b plus ribavirin in a real-life clinical setting in Japan : PERFECT interim analysis
- Demonstration of quality of care measurement using the Japanese liver cancer registry
- Serum HBV RNA as a possible marker of HBV replication in the liver during nucleot(s)ide analogue therapy
- Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C : a nationwide multicenter cooperative study
- Fibrosis score consisting of serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B